The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens

被引:106
作者
Kankaanpää, A [1 ]
Meririnne, E [1 ]
Lillsunde, P [1 ]
Seppälä, T [1 ]
机构
[1] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Lab Subst Abuse, FIN-00300 Helsinki, Finland
关键词
serotonin (5-HT); dopamine; DOM; MDA; MDMA; amphetamine; microdialysis;
D O I
10.1016/S0091-3057(97)00527-3
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The acute effects of amphetamine derivatives on extracellular concentration of serotonin (5-HT) and dopamine in the nucleus accumbens were studied with in vivo microdialysis using conscious, freely moving rats. 5-HT, dopamine, and their major metabolites were measured by HPLC with electrochemical detection. Amphetamine (1.0-9.0 mg/kg) elevated dopamine levels considerably, but failed to affect the levels of 5-HT, except at the highest dose administered. 3,4-Methylenedioxyamphetamine (MDA, 1.0-9.0 mg/kg) and 3,4-methylenedioxymethamphetamine (MDMA, 1.0-9.0 mg/kg) elevated both 5-HT and dopamine levels dose dependently. The failure of 2,5-dimethoxy-4-methylamphetamine (DOM, 0.5-1.0 mg/kg) to affect the 5-HT levels suggests that extracellular levels of 5-HT play a minor role in hallucinogenic activity. The strong effects of MDA and MDMA on levels of 5-HT indicate that their actions on serotonergic mechanisms are different from those of the hallucinogens. In addition, methylenedioxyamphetamines may act via dopaminergic mechanisms similar to those of amphetamine. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:1003 / 1009
页数:7
相关论文
共 31 条
[1]  
BLASCHKO H, 1952, PHARMACOL REV, V4, P415
[2]   AMPHETAMINE, COCAINE, PHENCYCLIDINE AND NOMIFENSINE INCREASE EXTRACELLULAR DOPAMINE CONCENTRATIONS PREFERENTIALLY IN THE NUCLEUS ACCUMBENS OF FREELY MOVING RATS [J].
CARBONI, E ;
IMPERATO, A ;
PEREZZANI, L ;
DICHIARA, G .
NEUROSCIENCE, 1989, 28 (03) :653-661
[3]  
FIBIGER HC, 1979, NEUROBIOLOGY DOPAMIN, P597
[4]  
Fuller R W, 1972, Adv Biochem Psychopharmacol, V5, P339
[5]  
GARATTINI S, 1981, HDB EXPT PHARM 2, V55, P545
[6]  
Glennon R A, 1990, NIDA Res Monogr, V105, P154
[7]  
Glennon R A, 1989, NIDA Res Monogr, V94, P43
[9]   ANTAGONISM OF THE EFFECTS OF THE HALLUCINOGEN DOM AND THE PURPORTED 5-HT AGONIST QUIPAZINE BY 5-HT2 ANTAGONISTS [J].
GLENNON, RA ;
YOUNG, R ;
ROSECRANS, JA .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1983, 91 (2-3) :189-196
[10]   EVIDENCE FOR 5-HT2 INVOLVEMENT IN THE MECHANISM OF ACTION OF HALLUCINOGENIC AGENTS [J].
GLENNON, RA ;
TITELER, M ;
MCKENNEY, JD .
LIFE SCIENCES, 1984, 35 (25) :2505-2511